Avenue Therapeutics Inc

NASDAQ:ATXI

0.29

-0.02 (-6.32%)

Products

Avenue Therapeutics Inc - On August 26, Co Received An Appeal Denied Letter From Office Of Neuroscience Of FDA

Published: 08/27/2021 13:32 GMT

Avenue Therapeutics Inc (ATXI) - Avenue Therapeutics Inc - on August 26, Co Received an Appeal Denied Letter From Office of Neuroscience of FDA.
Avenue Therapeutics Inc - Intends to Continue to Pursue Regulatory Approval for Iv Tramadol.
Further Company Coverage: Atxio (((reuters.
Briefs@thomsonreuters.
Com);)).